← Back to guidelines
Gastroenterology9 papers

Gastroesophageal reflux disease with ulcer

Last edited: 4/15/2026

Overview

Gastroesophageal reflux disease (GERD) with ulceration involves the development of ulcers in the esophagus due to persistent acid reflux, often requiring targeted management beyond standard GERD treatment 1.

Diagnosis

  • Presence of typical GERD symptoms (heartburn, regurgitation) with endoscopic evidence of esophageal ulcers 1.
  • pH monitoring or impedance testing to confirm acid reflux 1.
  • Exclusion of other causes of esophageal ulcers, such as infections or eosinophilic esophagitis, through biopsy and appropriate testing 1.
  • Management

  • First-line treatments:
  • - Proton pump inhibitors (PPIs) at high doses (e.g., omeprazole 40 mg daily) to suppress acid secretion 1. - H2 receptor blockers as adjunctive therapy if PPIs are insufficient 1.
  • Adjunctive treatments:
  • - Tissue debridement and infection control if infection is suspected 1. - Management of moisture imbalance and wound care to promote healing 1. - Collaboration with specialists for comorbidities affecting ulcer healing 1.

    Special Populations

  • Comorbidities: Management should consider and address patient comorbidities and risk factors for poor healing, often necessitating multidisciplinary care 1.
  • Key Recommendations

  • Implement etiology-specific treatment, primarily high-dose proton pump inhibitors, to manage acid suppression and promote ulcer healing (Evidence: Strong 1).
  • Tailor ulcer care strategies including debridement and infection control as needed, adapting management based on ulcer status changes (Evidence: Moderate 1).
  • Address patient comorbidities and risk factors through interdisciplinary collaboration to optimize healing outcomes (Evidence: Expert opinion 1).
  • References

    1 Hines A, Kody S, Shakshouk H, Fett N, Alavi A, Ortega-Loayza AG. Inflammatory and vaso-occlusive ulcers: Part II - Management. Journal of the American Academy of Dermatology 2024. link 2 Rudin SA. National motives predict psychogenic death rates 25 years later. Science (New York, N.Y.) 1968. link

    Original source

    1. [1]
      Inflammatory and vaso-occlusive ulcers: Part II - Management.Hines A, Kody S, Shakshouk H, Fett N, Alavi A, Ortega-Loayza AG Journal of the American Academy of Dermatology (2024)
    2. [2]
      National motives predict psychogenic death rates 25 years later.Rudin SA Science (New York, N.Y.) (1968)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG